Document is current
Any future updates will be listed below
-
Authors
Proskocil, Becky J.
Wai, Karol
Lebold, Katherine M.
Norgard, Mason A.
Michaelis, Katherine A.
De La Torre, Ubaldo
Cook, Madeline
Marks, Daniel L.
Fryer, Allison D.
Jacoby, David B.
Drake, Matthew G. http://orcid.org/0000-0001-5476-0361
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL121254, HL144008, HL113023, HL155623)
National Institute of General Medical Sciences (GM118964)
Collins Medical Trust
American Thoracic Society
American Lung Association
National Cancer Institute (CA184324, CA217989)
- License Information
-
More Information
Article History
Received: 24 December 2020
Accepted: 31 August 2021
First Online: 16 September 2021
Declarations
:
: Animals were treated in accordance with the standards established by the United States Animal Welfare Act set forth by the National Institutes of Health guidelines. The Institutional Animal Care and Use Committee at Oregon Health & Science University approved all experimental protocols.
: Not applicable.
: DM declares he is a paid consultant for Pfizer, Inc.; Alkermes, Inc.; and Tensive Controls, Inc. MD reports he is a paid consultant for GlaxoSmithKline and AstraZeneca.
